BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 485546)

  • 1. [T antigen and CEA; comparison between 2 tumor markers in breast cancer and malignant gynecologic neoplasms].
    Scheiffarth OF
    Arch Gynecol; 1979 Jul; 228(1-4):659-60. PubMed ID: 485546
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Carcinoembryonic antigen in gynecological oncology].
    Stiglmayer R
    Fortschr Med; 1978 Oct; 96(37):1843-5. PubMed ID: 700565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Carcino-embryogenic antigen (CEA) in patients with genital tumors (author's transl)].
    Anger H; Gleissenberger U
    Geburtshilfe Frauenheilkd; 1977 Jul; 37(7):604-8. PubMed ID: 885332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical evaluation of a new tumor marker, CA 15-3, in breast cancer; a comparative study with CEA].
    Komuro K; Watanabe K; Ishida T; Sakurai M; Amano R; Hagiwara H; Hara Y; Hanzawa T; Itsubo K
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3145-9. PubMed ID: 3465273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential immunocytochemical localization of tissue polypeptide antigen (TPA) and carcinoembryonic antigen (CEA) in breast cancer.
    Björklund V; Björklund B
    Cancer Detect Prev; 1983; 6(1-2):193-8. PubMed ID: 6883380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of tumor antigens in gynecologic malignancies.
    Gall SA
    J Reprod Med; 1975 Jan; 14(1):12-6. PubMed ID: 162963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The expression of leukocytic and related antigens on the cells of human breast cancer cells].
    Tupitsyn NN; Kadagidze ZG; Blokhina NG; Baryshnikov AIu; Ermilova VD; Artamonova EV; Moldenhauer G; Bernard A
    Eksp Onkol; 1990; 12(2):54-8. PubMed ID: 1690634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical use of gynaecologic tumour markers.
    Halila H; Alfthan H; Stenman UH
    Ann Chir Gynaecol; 1989; 78(1):65-70. PubMed ID: 2547331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
    Forti E; Wolf D; Melia M
    Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor and serum CEA content in gynecologic neoplasms.
    Kula J; Richter R; Gawlikowski W; Harłozińska A
    Neoplasma; 1984; 31(1):89-93. PubMed ID: 6322027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients.
    Shively JE; Spayth V; Chang FF; Metter GE; Klein L; Presant CA; Todd CW
    Cancer Res; 1982 Jun; 42(6):2506-13. PubMed ID: 7074626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative evaluation of tumor markers (TPA and CEA) in various malignant neoplasms at an advanced stage].
    Meregalli M; Antoniazzi V; Torchio G; Colombo E; Bocchi M; Sonzini E; Lino S
    Minerva Med; 1989 Apr; 80(4):345-7. PubMed ID: 2725935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The place of tumor markers in breast and gynecologic neoplasms].
    Gosselin P; Cazin JL; Demaille MC; Sulman C
    Rev Fr Gynecol Obstet; 1988; 83(7-9):535-40. PubMed ID: 3057569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Markers in breast cancer].
    Sulitzeanu D
    Harefuah; 1982 Jun; 102(11):493-4. PubMed ID: 7160693
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical evaluation of an immunoradiometric assay for CA15-3 antigen associated with human mammary carcinomas: comparison with carcinoembryonic antigen.
    Fujino N; Haga Y; Sakamoto K; Egami H; Kimura M; Nishimura R; Akagi M
    Jpn J Clin Oncol; 1986 Dec; 16(4):335-46. PubMed ID: 3467106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunomorphologic markers in breast cancer].
    Volchenko NN; Litvinova LV; Pugachev KK; Shimbireva IB; Kalashnikov VV; Frank GA
    Arkh Patol; 1996; 58(1):6-10. PubMed ID: 8929144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical evaluation of serum CA-50 measurement in breast diseases --relation to the progress of breast cancer].
    Shiga T; Kawauchi A; Kamiya K; Ishii J; Uzawa R; Gomi K
    Rinsho Byori; 1986 Nov; 34(11):1339-45. PubMed ID: 3469447
    [No Abstract]   [Full Text] [Related]  

  • 19. [Significance of the contemporary determination of tumor associated antigens in patients with various types of neoplasms of the genital tract].
    Sacco F; Benedetti Panici P; Villani L; Di Roberto P; Barile G; Iacobelli S
    Minerva Ginecol; 1978 Oct; 30(10):811-6. PubMed ID: 82920
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT
    Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.